François D’Anjou

419 total citations
12 papers, 352 citations indexed

About

François D’Anjou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, François D’Anjou has authored 12 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in François D’Anjou's work include Ubiquitin and proteasome pathways (4 papers), Peptidase Inhibition and Analysis (3 papers) and Prostate Cancer Treatment and Research (3 papers). François D’Anjou is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Peptidase Inhibition and Analysis (3 papers) and Prostate Cancer Treatment and Research (3 papers). François D’Anjou collaborates with scholars based in Canada, France and United States. François D’Anjou's co-authors include Robert Day, Frédéric Couture, Roxane Desjardins, Michel Salzet, Isabelle Fournier, Jean‐Pierre Perreault, François Boudreau, Sophie Routhier, Alain Latil and David Bonnel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Cancer and Metastasis Reviews.

In The Last Decade

François D’Anjou

11 papers receiving 340 citations

Peers

François D’Anjou
Chu Myong Seong South Korea
Neelam V. Desai United States
Seung Oe Lim South Korea
Huihong You United States
François D’Anjou
Citations per year, relative to François D’Anjou François D’Anjou (= 1×) peers Mamoru Takada

Countries citing papers authored by François D’Anjou

Since Specialization
Citations

This map shows the geographic impact of François D’Anjou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François D’Anjou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François D’Anjou more than expected).

Fields of papers citing papers by François D’Anjou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François D’Anjou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François D’Anjou. The network helps show where François D’Anjou may publish in the future.

Co-authorship network of co-authors of François D’Anjou

This figure shows the co-authorship network connecting the top 25 collaborators of François D’Anjou. A scholar is included among the top collaborators of François D’Anjou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François D’Anjou. François D’Anjou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Couture, Frédéric, Christine Levesque, Véronique Dumulon‐Perreault, et al.. (2014). PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered 64Cu-Radiolabeled Peptide Inhibitor. Neoplasia. 16(8). 634–643. 12 indexed citations
2.
D’Anjou, François, Frédéric Couture, Roxane Desjardins, & Robert Day. (2013). Knockdown Strategies for the Study of Proprotein Convertases and Proliferation in Prostate Cancer Cells. Methods in molecular biology. 1103. 67–82. 7 indexed citations
3.
Gagnon, Hugo, Anna Kwiatkowska, Frédéric Couture, et al.. (2013). Optimization of Furin Inhibitors To Protect against the Activation of Influenza Hemagglutinin H5 and Shiga Toxin. Journal of Medicinal Chemistry. 57(1). 29–41. 25 indexed citations
4.
Longuespée, Rémi, Annie Desmons, D. Vinatier, et al.. (2012). Ovarian cancer molecular pathology. Cancer and Metastasis Reviews. 31(3-4). 713–732. 50 indexed citations
5.
Couture, Frédéric, François D’Anjou, Roxane Desjardins, François Boudreau, & Robert Day. (2012). Role of Proprotein Convertases in Prostate Cancer Progression. Neoplasia. 14(11). 1032–IN6. 51 indexed citations
6.
Gagnon, Sandra, Hugo Gagnon, Roxane Desjardins, et al.. (2012). Disruption of Proprotein Convertase 1/3 (PC1/3) Expression in Mice Causes Innate Immune Defects and Uncontrolled Cytokine Secretion. Journal of Biological Chemistry. 287(18). 14703–14717. 33 indexed citations
7.
Levesque, Christine, Martin Fugère, Anna Kwiatkowska, et al.. (2012). The Multi-Leu Peptide Inhibitor Discriminates Between PACE4 and Furin And Exhibits Antiproliferative Effects On Prostate Cancer Cells. Journal of Medicinal Chemistry. 55(23). 10501–10511. 40 indexed citations
8.
D’Anjou, François, Sophie Routhier, Jean‐Pierre Perreault, et al.. (2011). Molecular Validation of PACE4 as a Target in Prostate Cancer. Translational Oncology. 4(3). 157–IN9. 58 indexed citations
9.
Couture, Frédéric, François D’Anjou, & Robert Day. (2011). On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications. BioMolecular Concepts. 2(5). 421–438. 55 indexed citations
10.
D’Anjou, François, Nadia Ben Larbi, Isabelle Fournier, et al.. (2004). Silencing of SPC2 Expression Using an Engineered δ Ribozyme in the Mouse βTC-3 Endocrine Cell Line. Journal of Biological Chemistry. 279(14). 14232–14239. 16 indexed citations
11.
Boctor, Fayez F., François D’Anjou, & Vincent Giard. (2001). Analyse théorique des décyclages sur ligne de production.
12.
D’Anjou, François, et al.. (2000). Analyse de la robustesse des ordonnancements / réordonnancements sur ligne de production et d'assemblage dans l'industrie automobile. Revue Française de Gestion Industrielle. 19(1). 17–36. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026